Seth Berkley, the CEO of the GAVI Vaccine Alliance, made know that although the facility was yet to conclude on a specific target price; the facility was considering a target price of $40 per COVID-19 dose for wealthy nations.

“There was a large range of numbers, and they (the EU sources) put the highest number out. COVAX officials had given a range of different prices. And $40 was the maximum price in the range for high-income countries, rather than a set price,” Reuters quoted him as saying.

While explaining that GAVI’s COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, has commenced the putting together of estimations based on known information, Berkley maintained that at the moment, the prices are yet to be concluded.

He further made known that it is presently not clear what manufacturers of potential COVID-19 vaccines will propose, but according to him, efforts made from GAVI so far, is putting forward cost estimates based on available information.

“The challenge is trying to come up with a cost. Anybody who tells you they know isn’t being honest,” Berkley added.

Know this…

Drug manufacturers like Moderna, have so far recorded positive results in their COVID-19 trials. And according to the World Health Organization (WHO), no less than 150 vaccines are at development stage across the world.

Wondering how long it will take to develop a vaccine and get it approved for COVID-19 cure? You don’t have to ponder anymore, as Wellcome Trust, a research-charity based in London recently revealed that normally, the research and discovery stage takes between two-to-five years. Corroborating this claim, the UK Charity Commission said a vaccine can take more than 10 years to fully develop.

The post COVID-19 Vaccine To Be Sold For N15,500 Per Dose appeared first on Business News in Nigeria.